Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Amphastar Pharmaceuticals, Inc. (AMPH) had Revenue of $170.53M for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$170.53M
Net Income	$25.29M
Cost of Goods Sold	$85.28M
Gross Profit	$85.25M
Operating Expenses	$133.24M
Operating Income	$37.29M
Non-Operating Income/Expense	$-6.43M
Pre-Tax Income	$30.86M
Normalized Pre-Tax Income	$30.86M
Income after Taxes	$25.29M
Income from Continuous Operations	$25.29M
Consolidated Net Income/Loss	$25.29M
Normalized Income after Taxes	$25.29M
EBIT	$37.29M
EBITDA	$51.66M
Weighted-Average Shares Outstanding (Basic)	47.64M
Weighted-Average Shares Outstanding (Diluted)	49.89M
Earnings per Share (EPS) (Basic)	$0.53
Earnings per Share (EPS) (Diluted)	$0.51
Balance Sheet Financials
Current Assets	$587.96M
Property, Plant, and Equipment	$307.60M
Long-Term Assets	$1.04B
Total Assets	$1.63B
Current Liabilities	$199.05M
Long-Term Debt	$603.86M
Long-Term Liabilities	$675.94M
Total Liabilities	$874.99M
Common Equity	$751.28M
Tangible Shareholders Equity	$166.75M
Shareholders Equity	$751.28M
Common Shares Outstanding	47.67M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$35.08M
Cash Flow from Investing Activities	$10.48M
Cash Flow from Financial Activities	$-14.50M
Beginning Cash	$151.84M
End Cash	$183.02M
Increase/Decrease in Cash	$31.17M
Stock-Based Compensation	$8.39M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.95
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.45
Debt to Equity Ratio	0.80
Gross Margin	49.99%
Operating Margin	21.87%
EBIT Margin	21.87%
EBITDA Margin	--
Pre-Tax Profit Margin	18.10%
Profit Margin	14.83%
Free Cash Flow	$24.38M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.10
Inventory Turnover	0.46
Receiveable Turnover	1.17
Days Sales in Receivables	76.73
Return on Equity	3.37%
Return on Tangible Equity	15.16%
Return on Assets	1.55%
Return on Investments	1.87%
Book Value Per Share	$15.76
Free Cash Flow per Share	$0.49
Operating Cash Flow per Share	$0.70

Data from Zacks Investment Research, Inc.